Skip to main content
Veterinary Medicines

NEOMETEORYL

Authorised
  • OLEOYL MACROGOLGLYCERIDES

Product identification

Medicine name:
NEOMETEORYL
Active substance:
  • OLEOYL MACROGOLGLYCERIDES
Target species:
  • Cattle
  • Sheep
  • Goat
Route of administration:
  • Intraruminal use
  • Oral use

Product details

Active substance and strength:
  • OLEOYL MACROGOLGLYCERIDES
    1.00
    millilitre(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Oral solution
Withdrawal period by route of administration:
  • Intraruminal use
    • Cattle
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • Sheep
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • Goat
      • Meat and offal
        0
        day
  • Oral use
    • Cattle
      • Milk
        0
        day
      • Meat and offal
        0
        day
    • Sheep
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • Goat
      • Meat and offal
        0
        day
      • Milk
        0
        day
      • Milk
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA03AX
Authorisation status:
  • Valid
Authorised in:
  • France
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Dopharma France S.A.S.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Dopharma France
Responsible authority:
  • National Veterinary Medicines Agency
Authorisation number:
  • FR/V/0293756 8/1992
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 24/03/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."